BakerHosts

Employees showing support for social justice movements are starting to wear their advocacy positions on their sleeve – or on their face coverings or t-shirts. Who gets to decide what is offensive and what is not, and how should employers decide what is allowed? Join Eric Barnum and Todd Lebowitz as they address these issues and provide a thoughtful and timely discussion relevant to many employers.

Questions & Comments: 

[email protected], [email protected]

Employees showing support for social justice movements are starting to wear their advocacy positions on their sleeve – or on their face coverings or t-shirts. Who gets to decide what is offensive and what is not, and how should employers decide what is allowed? Join Eric Barnum and Todd Lebowitz as they address these issues and provide a thoughtful and timely discussion relevant to many employers.

Questions & Comments: 

[email protected], [email protected]

Pharmaceutical companies only need patents for compositions of matter and general methods of use, right? Wrong. Discoveries can happen well into Phase III and IV and pharmaceutical companies should seek patent protection for those later-developed inventions. Partner and co-leader of the Biotechnology, Chemical, and Pharmaceutical patent prosecution team, Stephanie Lodise discusses how and why clinical stage patent protection can drive innovation in small molecule pharmaceutical development.

Questions & Comments: [email protected]

Just how much impact is the global pandemic having on foreign national workers and business immigration? Matt Hoyt addresses this question and gives us a breakdown of which foreign national workers are most at risk and how companies can prepare for possible slowdowns in application processing. Matt is a partner in BakerHostetler’s Labor and Employment Group and leads our Immigration practice.

Questions & Comments: [email protected]